GLP-1 Weight Loss Medications

Educational resource on the GLP-1 receptor agonist class of medications, including the FDA-approved brand-name products and Weight Method's compounded programs. Weight Method does not dispense or prescribe brand-name Ozempic®, Wegovy®, Mounjaro®, or Zepbound®. Compounded medications are not FDA-approved.

Compounded semaglutide & tirzepatide prescribed by licensed providers. Delivered to your door.

Take the Free Quiz

Free consultation · No commitment · Results in weeks

Patient
Patient
Patient
Patient
Patient
4.9/5

From 2,000+ patients · GLP-1 is already seeing results

Licensed Providers
FDA-Approved Medications
Free Shipping
HIPAA Compliant

Generic Medications

Brand-Name Medications

Ready to Get Started?

Answer a few quick questions to see if you qualify.

Check Eligibility

Your Treatment Options

Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Starting at$199/mo
Semaglutide
Most PopularIn Stock

Semaglutide

Compounded semaglutide. Once-weekly subcutaneous injection.

  • Weekly injection
  • Gradual dose increase
  • Provider monitoring
  • Free shipping
Check Eligibility
Tirzepatide
In Stock

Tirzepatide

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.

  • Weekly injection
  • Dual hormone action
  • Provider monitoring
  • Free shipping
Check Eligibility

Frequently Asked Questions

Weight Method's prescribing providers issue patient-specific prescriptions for compounded semaglutide or compounded tirzepatide, dispensed by U.S.-licensed 503A compounding pharmacies. Weight Method does not dispense or prescribe brand-name Ozempic®, Wegovy®, Mounjaro®, or Zepbound®. Compounded medications are not FDA-approved.

The compounded semaglutide program starts at $154/month and the compounded tirzepatide program starts at $329/month. Pricing includes the medication, the licensed-provider evaluation, ongoing provider access, dose management, and home shipping. Compounded medications are not FDA-approved.

Semaglutide is a GLP-1 receptor agonist; tirzepatide is a dual GIP/GLP-1 receptor agonist that acts on a second hormone pathway in addition to GLP-1. Both regulate appetite and slow gastric emptying. Any published clinical-trial outcomes were generated using the FDA-approved reference products. Compounded versions are not FDA-evaluated.

Yes. GLP-1 medications require a prescription from a licensed medical provider. Weight Method includes a virtual evaluation by a licensed provider as part of every plan.

Most patients are reviewed within 24-48 hours of completing the online assessment. Once approved, medication ships directly to your door within a few business days.

Start Your GLP-1 Treatment

Virtual consultation with licensed providers. Medication shipped to your door from $199/mo.

Get Started

Free consultation. No commitment.

More About GLP-1